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Abstract 
The focus of this descriptive comparative study was to examine the relationship between 
gender and depression and immune system function in patients with colorectal cancer. 
The research questions were answered through secondary analysis, using data obtained 
from the answers of 117 men and women (71 men and 46 women) enrolled in a 
colorectal cancer study conducted between 1990 and 1991 in Pennsylvania. Descriptive 
statistics were used to characterize the sample, and general estimating equations were 
used to analyze depression and immune system function between men and women. 
Depression was measured by the Beck Depression Inventory, and immune system 
function was measured by natural killer cell levels. Results indicated that women 
reported higher levels of depression at all points in time, but the results were not 
statistically significant (B=2.065,/?=.151). Age was statistically significant (B=4.180, 
p=.04l). Women did not demonstrate statistically significantly lower NK cell levels than 
men (B=..271,p=.603) using GEE, although at all points in time, men's NK cell levels 
were higher than women's. Age was not a significant factor in the NK cell level 
differences (B=3.667,/>=.056). The study was confounded by the relatively small sample 
size, and the high drop-out rate. 
CHAPTER 1 
INTRODUCTION 
Cancer is the second most frequent cause of death in the United States, and 
colorectal cancer is the third most frequently diagnosed malignancy in both men and 
women (ACS, 2005). Although colorectal cancer rates have been steadily declining for 
the past 50 years, its five year survival is only 65% for white patients of both genders, 
and 55% for African-American men and women. According to the American Cancer 
Society, cancer will strike 679,510 women each year and of these women, 11% will be 
diagnosed with colorectal cancer, only slightly less than the number diagnosed with 
breast cancer (Society 2005)). 
Statement of the Problem 
Women have traditionally been underrepresented in medical studies, even though 
men and women have approximately the same lifetime risk (5.9% and 5.5% respectively) 
of being diagnosed with the disease. Colon cancer incidence rises with age; 91% of new 
cases are found in patients over the age of 50 (ACS, 2005). Compared to patients aged 
less than 40, there is a 50-fold increase in colon cancer in patients aged 60-79 (ACS, 
2005). Colorectal cancer prognosis is directly related to the extent the tumor has entered 
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the bowel wall, the presence of lymph node involvement, and the presence of metastasis 
(National Cancer Institute, 2007). 
Early diagnosis through screening beginning at age 50 is key to survival. Annual 
fecal occult blood testing (FOBT), primarily using rehydrated samples decreased 
mortality from colorectal cancer by 33% in study of 48,000 patients (Mandel, Bond et al., 
1993). Screening sigmoidoscopy, using either a flexible or rigid sigmoidoscope, reduced 
the mortality risk by 70% -90% in two studies of screened patients compared to patients 
who were not screened (Selby, Friedman et al., 1992); (Newcomb, Norfleet et al., 1992). 
The American Cancer Society recommends that adults begin yearly FOBT screening at 
age 50, with sigmoidoscopy every five years (ACS 2005). Recurrent disease is found in 
up to 33% of patients (Safi, Link et al., 1993), leading to repeated treatment. 
Patients with depression are less likely to continue in rigorous treatment and 
screening regimens. Depression has also been implicated in reduced functioning of the 
immune system, including the tumor surveillance function of the immune system. Yet 
little data exists about any differences between the immune systems of men and women, 
and depression in men and women who are diagnosed with colorectal cancer. A link 
between depression and immune system function can serve to identify those patients most 
at risk for complications, and those at risk of failing to continue treatment in follow-up 
care. Research is needed to examine the effects of colorectal cancer on men and women, 
and the differences, if any, in depressive symptoms and objective markers of immune 
function. The majority of completed studies did not include women, or did not analyze 
the women as a group separate from the men. Women are more likely to suffer from 
depression, and depression has been associated with reduced immune function. If women 
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with colorectal cancer are more depressed than men, one would expect that their immune 
function would suffer, leading to (potentially) more complications and poorer healing. 
Purpose of the Study 
Psychological state, particularly depression, has been implicated in reduced 
functioning of the immune system. Researchers have demonstrated diminished natural 
killer T-cell counts in patients reporting depression (Zorilla, Luborsky et al., 2001). In 
addition, numerous researchers have documented differences in levels of reported 
depression between men and women with cancer. Whether these differences are also 
reflected in patients' reports of depression over time has yet to be determined. Similarly, 
research has not established whether differences in depression translate into significant 
differences in immune system function between genders. The purpose of this study was 
to examine differences in levels of depression and immune function at three points in 
time of the colorectal cancer treatment trajectory. 
The study consisted of a secondary analysis of data obtained from a study 
performed by Dr. Ruth McCorkle, from 1991 to 1992. The aim of the original study, 
supported by NIH grant P50 NR 02324, was to examine the physiological and 
psychological responses over time of patients with colorectal cancer. The McCorkle 
research team investigated whether outcome expectations and emotional distress changed 
over time, examined the interactions (if any) of outcome expectations and immune 
status, and whether outcome expectations and coping changed, or were related 
(Barsevick, Pasacreta et al., 1995; Orsi, McCorkle et al., 1996; Orsi, Tax et al., 1996). 
Orsi, McCorkle, Tax, and Barsevick (1996) examined the relationship between 
depression, depressive symptoms, and the immune system in patients with colorectal 
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cancer. Sixty-three patients were studied six months post diagnosis. Fourteen percent of 
patients reported depressive symptoms. Levels of NK cells were significantly lower in 
patients with more severe depressive symptoms both preoperatively and postoperatively. 
In addition, NK cell counts were lower than average in patients with more severe 
depressive symptoms. Preoperative depressive symptoms predicted NK counts and 
CD4/CD8 ratios (Orsi, McCorkle et al., 1996). Differences by gender were not 
examined, although women comprised between 32% and 39% of the sample, rather men 
and women were analyzed as one group. Findings indicated twice as many men as 
women in the sample reported no or minimal symptoms depressive symptoms at the first 
pre-operative visit, although women in general suffer from depression at roughly twice 
the rate of men. However, there was no separate analysis of the effect of gender on the 
interaction of depression and natural killer cell levels. This clearly requires further 
investigation. 
Specific Aims 
The specific aims of this study were to: 
1) Determine if there were differences between reported depression levels in men and 
women diagnosed with colorectal cancer at four points in time (day of surgery, one week 
post surgery, three months post surgery, and six months post surgery). 
2) Describe the differences, if any, in NK cell levels in men and women diagnosed with 
colorectal cancer at three points in time (day of surgery, three months post surgery, and 
six months post surgery). 
Conceptual Framework 
The conceptual framework of the study was based on the work of McCorkle 
integrating expectations about outcome of cancer treatment, depression, and immune 
response in person recovering from surgery for colorectal cancer (Figure 1.) (Orsi, 
McCorkle et al., 1996). The model posits that emotional distress, defined here as 
depression, leads to impaired immune responses (measured by NK cell level). 
Figure 1. 
Research Questions 
1. Are women more likely to report more depressive symptoms than men in 
adult patients diagnosed with colorectal cancer at four points in time (pre-surgical, 1 
week post-surgery, one month post-surgery, and three months post surgery)? 
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2. Do women demonstrate lower NK cell levels in adult patients diagnosed with 
colorectal cancer at three points in time (pre-surgical, one week post-surgery, and three 
months post surgery)? 
Hypotheses 
Based on gender differences in depression and reactions to the cancer diagnosis, 
and the already discovered interaction between NK cells and depression, the following 
hypotheses will be tested: 
HI: Women will report a greater incidence of moderate to severe depressive symptoms. 
H2: Women will demonstrate a more prolonged duration of depressive symptoms than 
men. 
Significance to Nursing 
The Healthy People 2010 Initiative (Office of Disease Prevention and Health 
Promotion, 2000) aimed to reduce deaths from colorectal cancer from 19.8 deaths per 
100,000 persons between 2000 and 2003, to 13.9 deaths per 100,000 persons in the 
United States. Detecting and removing precancerous colorectal polyps and detecting and 
treating the disease in its earliest stages will reduce deaths from colorectal cancer (Office 
of Disease Prevention and Health Promotion, 2000). Detected at its earliest stages, 
colorectal cancer has a five year survival rate of 90%. However, only 38% of cases are 
diagnosed while the tumor is confined to the wall of the bowel (Ries, Eisner et al., 2002). 
Early detection is key to patient survival. 
Healthy People 2010 lists depression as the most common disorder of mental 
illness (Office of Disease Prevention and Health Promotion, 2000), p. 36. Objective 18-
9b aims to increase the proportion of adults with recognized depression who receive 
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treatment (p 36). Depression strikes twice as many women as men (Office of Disease 
Prevention and Health Promotion, 2000) p 37, and depression rates are higher in adults 
with coincident medical conditions. Some research has been conducted on the impact of 
a cancer diagnosis on state of mind. Stommel, Kurtz, Given, and Given (2004) studied 
860 older patients for one year after a cancer diagnosis; they found that depression was 
predicted by cancer site and stage, co-morbidities, sociodemographic characteristics, and 
indicators of physical functioning(Stommel, Kurtz et al., 2004). Arndt, Merx, Stegmaier, 
Ziegler, and Brenner (2004) assessed quality of life in 439 patients in Germany one year 
after diagnosis with colorectal cancer(Arndt, Merx et al. 2004). Patients with colorectal 
cancer scored their physical, role, and cognitive, and global health functioning only 
slightly worse than the general population. However, patients described more severe 
limitations on the emotional and social functioning scales, as well as for physical 
symptoms and financial difficulties. Ramfelt, Severinsson, and Lutzen (2002) used a 
qualitative method to examine the emotional and interactional perspectives of the 
meaning of illness in 52 patients with colorectal cancer over the course of 12 months 
following diagnosis(Ramfelt, Severinsson et al., 2002). Using constant comparative 
analysis, the researchers described a process in which patients tried to find meaning in 
illness to achieve emotional coherence. 
Klemm, Miller, and Fernsler (2000) examined the demands the illness of 
colorectal cancer placed on 121 patients over time. Ninety-three percent of participants 
thought about the value of life and how long they might live. Participants reported that 
colorectal cancer placed the greatest demands on them in the realm of personal meaning, 
and noted significant psychological and existential concerns (Klemm, Miller et al., 2000). 
8 
Galloway and Gray don (1996) examined the relationship between uncertainty, 
symptom distress, and discharge information needs in 40 patients after colon resection for 
cancer. Patients identified information about treatment, complications, and activities of 
daily living as highly important. Increased uncertainty was significantly associated with 
increased discharge information needs (Galloway & Graydon, 1996). 
Course of Treatment 
Treatment of colorectal cancer depends upon the stage of the disease at the time 
of diagnosis. Colorectal cancer is staged according the TNM classification system by 
recommendation of the American Joint Committee on Cancer (Cancer 2003). The TNM 
system classifies tumors according to the tumor's invasion of the surrounding tissue, 
involvement of regional lymph nodes, and evidence of distant metastasis. As the tumor 
grows, it progressively invades the layers of the colon from the interior to the exterior; 
survival depends upon the degree of invasion of the colon and surrounding lymph nodes, 
and metastasis to distant structures. Treatment in all stages begins with local excision of 
the tumor, either polypectomy or laparoscopic or open surgical resection, with regional 
lymph node dissection. Because colorectal cancer spreads aggressively through the 
lymphatic system, it is recommended that at least 12 lymph nodes be examined to 
confirm the absence of nodal involvement by tumor (National Cancer Institute, 2003). In 
some cases, aggressive tumors which are too large to be excised are treated with 
debulking and adjuvant therapy such as chemotherapy and radiation therapy. Creation of 
a temporary or permanent colostomy is dependent on the size of the lesion and its 
location. In addition, patients may be referred for consideration for inclusion in clinical 
trials of biological or chemotherapy regimens. 
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Patients with extensive disease and metastases may face protracted courses of 
adjuvant therapy. How patients cope with the diagnosis and treatment of all types of 
cancer has been studied in both men and women, both qualitatively and quantitatively. 
Colorectal cancer places significant psychological, social, and physical demands on the 
patient, and all three domains have been studied. However, the impact of gender has not 
been studied. 
Definition of Terms 
Colorectal cancer: Cancer that develops in the colon (the longest part of the large 
intestine) and/or the rectum. Colorectal cancer encompasses a broad spectrum of 
neoplasms ranging from benign growths to invasive tumors. The predominant cancer is 
derived from the epithelial tissue of the colon and rectum. Lesions are classified into 
three groups: 1) non-neoplastic polyps; 2) neoplastic polyps; 3) cancers. 
Natural killer cells: Natural killer (NK) cells are small subset of large, granular 
lymphocytes, but are neither B cell nor T cell lymphocytes. Natural killer cells possess 
spontaneous cytotoxic activity against a wide variety of cells such as tumor cells and cells 
infected with viruses. This activity occurs independently of any interaction with major 
histocompatibilty complexes. In addition, NK cells influence lymphokine production, 
and regulate humoral and cytotoxic immune responses, as well as hematopoiesis. Natural 
killer cells activated by interleukin-2 (IL-2) serve to suppress tumor metastasis (Orsi, 
Taxetal., 1996). 
CEA: Carcinoembryonic antigen. A substance that is sometimes found in an increased 
amount in the blood of people who have certain cancers, other diseases, or who smoke. It 
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is used as a tumor marker for colorectal cancer. Higher levels of CEA prior to treatment 
for colorectal cancer correlate with poor survival (Filella, Molina et al., 1992). 
Chemotherapy: Treatment with drugs that kill cancer cells. 
Polyp: A growth that protrudes from a mucous membrane. 
Polypectomy: Surgery to remove a polyp. 
Biological therapy: Treatment to stimulate or restore the ability of the immune system to 
fight cancer, infections, and other diseases. Also used to lessen certain side effects that 
may be caused by some cancer treatments. Also called immunotherapy, biotherapy, 
biological response modifier (BRM) therapy, and BRM therapy. 
Radiation therapy: The use of high-energy radiation from x-rays, gamma rays, neutrons, 
and other sources to kill cancer cells and shrink tumors. Radiation may come from a 
machine outside the body (external-beam radiation therapy), or it may come from 
radioactive material placed in the body near cancer cells (internal radiation therapy, 
implant radiation, or brachytherapy). Systemic radiation therapy uses a radioactive 
substance, such as a radiolabeled monoclonal antibody, that circulates throughout the 
body. 
Assumptions 
The assumptions on which this study was based include: 
1. All information collected by the primary investigators is accurate, and 
reflects information about the course of treatment for colorectal cancer. 
2. All patients were treated as similarly as possible according to their 
diagnostic stage and colorectal cancer treatment protocols. 
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3. All patients had economic access to equivalent levels of care for colorectal 
cancer treatment. 
CHAPTER II 
REVIEW OF THE LITERATURE 
Colorectal Cancer Incidence and Course of Treatment 
Although the incidence of colorectal cancer has declined since 1998, it continues 
to be the third most frequently diagnosed malignancy in men and women (Society 2005). 
Colorectal cancer is considered to be a disease of the elderly, with over 91% of new cases 
and 94% of deaths occurring in patients older than 50. The incidence of colorectal cancer 
is 50 times higher in patients aged 60-79 than in those under the age of 40 (ACS, 2005). 
Because of its high frequency in the aging population, colorectal cancer and patients' 
reactions to it have been studied extensively. In addition to physiological reactions to 
surgery and adjuvant therapies, much attention has been directed at how patients think 
and feel over the course of treatment. 
Depression and Cancer 
Psychological responses to both the cancer diagnosis and course of treatment have 
been studied since the 1970s. Wiesman and Worden (1976), Oberst and Scott (1984), 
Morris, Greer and White (1977), and Hughes (1982) examined the psychological 
responses of patients after various cancer diagnoses at various stages of diagnosis and 
treatment; emotional distress was common. Weisman and Worden (1976) used a sample 
of 120 patients with five different cancers (breast, lung, colon, Hodgkin's disease, and 
malignant melanoma) to examine the effect of expectations and emotional distress on 
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coping and health. Over the course of 100 days, patients were given the Minnesota 
Multiphasic Personality Inventory (MMPI), the Thematic Apperception Test (TAT), and 
the Profile of Mood States (POMS) in addition to scales on coping, resolution, 
predominant concerns, and vulnerability which were designed for the study. Patients 
were interviewed by social workers in an initial semi-structured interview and at four to 
six week intervals. Patients with high emotional distress attempted to cope by reducing 
their negative moods, such suppression, submission, and stoicism. While some relief was 
found through the use of these tactics, they did ultimately resolve the underlying 
problems. Patients with lower emotional distress used more functional strategies such as 
eliciting partnerships with others and problem-focused tactics to resolve problems. While 
they found that emotional distress and a pessimistic outlook were related, Weisman and 
Worden did not examine the interrelationships between coping and expectations, leading 
to a linear picture of cancer coping. Men and women were not analyzed separately. The 
majority of the women in the study had been diagnosed with breast cancer, although 
more women than men in the study had colon cancer(Weisman and Worden, 1976). 
Oberst and Scott (1988) examined 40 patient-spouse dyads in which the patient 
had been diagnosed with colorectal or urinary cancer. Dyads were assessed at six points 
in the post-surgical period: pre-discharge, 10 days, 30 days, 60 days, 90 days, and 180 
days post discharge; the Brief Symptom Inventory, the State-Trait Anxiety Inventory, the 
Vulnerability Scale, and an inventory of concerns and problems were used. Both ostomy 
and non-ostomy patients were used. Both spouses and patients reported similar numbers 
of problems and concerns. Spouses reported more problems with their own physical 
states and with emotional difficulty and handling their own feelings. Spouses reported 
more lifestyle disruptions than patients. Spouses consistently reported more anxiety than 
patients did at 90 days, and prior to discharge. All dyads exhibited symptoms which had 
not resolved in the 180 day study period. The study was limited by its small sample size, 
and use of a relatively homogenous sample of middle to upper income families. No 
effort was made to distinguish between male and female patients in the analysis, and 
depression was not specifically addressed (Oberst & Scott, 1988). 
Stommel, Kurtz, Given, and Given (2004) looked at depression in 860 older 
patients for one year after a cancer diagnosis, using the using the center for 
Epidemiological Studies Depression Scale (CES-D). In the 393 patients who completed 
the full study, they found that depression was predicted by cancer site and stage, co-
morbidities, education, gender, and a history of emotional problems. Overall depressive 
symptoms declined over the course of the investigation, especially depressive mood and 
somatic indicators. As might be expected, women exhibited higher depression scores 
than men, although education, history of emotional problems, and site of cancer in the 
lung had the highest association with depression. The study was limited to patients who 
could be accessed by telephone, lived in Michigan, and spoke English. Only patients 
aged 65 or older were recruited. The use of the CES-D also raises some concerns. The 
CES-D has been criticized for its questions about somatic symptoms; researchers have 
speculated that such questions might lead to exaggerations and over-reporting of 
depressive symptoms(Stommel, Kurtz et al., 2004). 
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Arndt, Merx, Stegmaier, Ziegler, and Brenner (2004) assessed quality of life in 
439 patients in Germany one year after diagnosis with colorectal cancer using the 
European Organization for Research and Treatment of Cancer (EORTC) Quality of Life 
questionnaire (QLQ-C30). This 30-item self-report cancer-specific survey measures 
health-related quality of life, and consists of five functional scales (physical, emotional, 
role, cognitive, and social function). In addition, the questionnaire also evaluates somatic 
symptoms such as fatigue and nausea and vomiting, and financial difficulties. In the 309 
patients who completed the full questionnaire, quality of life was most affected by fatigue 
and insomnia. Patients with colorectal cancer scored their physical, role, and cognitive, 
and global health functioning only slightly worse than the general population. No 
patterns related to gender were seen. However, patients described more severe 
limitations on the emotional and social functioning scales, as well as for physical 
symptoms and financial difficulties. The study was limited in that it did not specifically 
assess depression or depressive symptoms scores. Patients were studied at one point in 
time rather than over time with repeated measures, and were compared to the general 
population rather than to themselves. Those who responded to the request to participate 
in the study were better educated than nonresponders, and tended to be married. There 
was no data on those patients who died in the year between diagnosis and the request to 
participate, and whose quality of life might presumably be different from patients who 
survived for one year (Arndt, Merx et al., 2004). 
Will (2002) used a constant comparative method to investigate the process by 
which patients learn to live with colorectal cancer. Using grounded theory, Will found 
that patients used a process of self-talk to work through the experience of colorectal 
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cancer. Patients experienced an 8 stage trajectory of living with colorectal cancer. 
Phases consisted of: (1) Knowing something is wrong; (2) seeking diagnosis; (3) 
receiving the diagnosis; (4) planning treatment; (50 being treated; (6) waiting and 
monitoring; (7) something is wrong again; (8) reflecting and moving on (Will, 2002). 
Depression and Natural Killer Cells 
Depression has long been known to have a significant effect on the immune 
system. Urch et al, (1988) compared the natural killer (NK) cell activity of in 
schizophrenics and patients with depression undergoing treatment with that of normal 
volunteers, and found that the schizophrenics had lower NK cell activity. 
Psychopharmacologic treatment led to increases in NK cell activity in the patients with 
schizophrenia, but not in those with depression. Urch et al concluded that the pituitary-
adrenal axis was responsible for the difference, and that the decrease in NK cell activity 
might be responsible for failures in immunosurveillance (Urch, Muller et al., 1988). 
Unfortunately, while the study contained equal numbers of men and women (30 each), 
the influence of gender was not examined. Failures in immunosurveillance have been 
implicated in an increase in cancers in patients with depression (Shekelle, Raynor et al., 
1981; Shavit, Lewis et al., 1984; Herberman & Ortaldo, 1981). 
Irwin et al (1988) examined NK cell activity during significant life events as well 
as during bereavement, and documented reduced NK cell activity in women anticipating 
or undergoing bereavement. Irwin found that in 28 women who were either grieving, or 
anticipating the death of a spouse, NK levels fell. However, the decrease in NK cell 
levels was not mediated by changes in plasma Cortisol levels; the adrenal cortex did not 
appear to influence the NK cell decline. The researchers did not, however, measure the 
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level of bereavement of the subjects, nor did they test for actual depression (Irwin, 
Daniels et al., 1988). 
Irwin, Smith, and Gillin (1987) also examined NK cell levels and activity in a 
small group of men hospitalized for treatment with diagnosed major depression. Using a 
sample of 19 men matched with 19 nonhospitalized normal volunteers, Irwin et al found 
that the depressed patients had significantly lower NK cell activity. Depression was 
measured with the Hamilton Depression Rating Scale, which has been criticized for not 
discriminating between symptoms related to anxiety, and those related to depression. 
Regrettably, no women were included in the study, so any possible gender differences 
could not be investigated (Irwin, Smith et al., 1987). 
In further work, Irwin et al (1987) explored the relationship between the effects of 
different life events on NK cells in women over a 3 month period. The Hamilton Rating 
Scale for Depression and the Social Readjustment Scale were used to quantify the 
women's states of mind. NK cell function was reduced in women with higher depression 
scores, as well as with higher scores on the Social Readjustment Rating Scale (Holmes & 
Rahe, 1967). Severity of depressive symptoms was accompanied by lower NK cell 
activity. However, the authors did not examine any differences between the effects of 
depression, and any effects of major life events (Irwin, Daniels et al., 1987). 
Levy, Herberman, Lippman, and d'Angelo (1987) found an association between 
breast cancer, depression and fatigue, and lack of support at the time of diagnosis, and 
reduced NK cell activity at three months after diagnosis. Seventy-five women diagnosed 
with stage I or stage II breast cancer in a study comparing modified radical mastectomy 
to wide excision with radical radiotherapy were enrolled in a study to examine the 
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influence of fatigue, global adjustment to cancer, and social support on NK cell levels. 
Previous work had established that peripheral NK cell levels predicted the presence of 
cancer cells in axillary lymph nodes (Levy et al, 1985). Patients were interviewed 
between five and seven days after surgery (mastectomy plus axillary node dissection, or 
lumpectomy and lymph node dissection). In addition to an interview, patients filled out 
the Profile of Mood States (POMS) self-report form, and were rated by two observers for 
overall adjustment to their illness using the Global Adjustment to Illness Score (GAIS). 
Assays of NK cells were taken at the time of the interview, as well as during an 
outpatient visit three months later. Patients with lymph nodes positive for cancer 
demonstrated low NK cell activity at initial interview and at the three month check-up. 
In these patients, neither chemotherapy nor chemotherapy with radiation led to further 
decreases in NK cell activity. Fatigue and social support accounted for 30% of the NK 
cell activity decreases at three months. Patients reporting depressive, fatigue-like 
symptoms and who reported a lack of family support at the first interview tended to show 
a decrease in NK cell activity at the three-month follow-up (Levy, Herberman et al., 
1987). Based on these results, it appears that depression and a perceived lack of social 
support at the time of initial surgery predicted NK cell activity three months later. The 
authors posited that a lack of NK cell activity would lead to reductions in cancer 
surveillance, and possibly an increase in the spread of the disease. However, no data 
were followed to substantiate that surmise. Patients in the study were young (mean age 
52), and no socio-economic data were provided. In addition, no data were provided 
about race, co-morbidities, or family constellation. 
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Vines, Gupta, Whiteside, Dostal-Johnson, and Hummler-Davis (2003) measured 
natural killer (NK) cell counts and self-reports of depression in 24 patients with chronic 
pain. Pain perception was positively correlated with depression and NK cell percentage. 
Immune system function as measured by NK cell levels was significantly higher in 
patients without pain (Vines, Gupta et al., 2003). 
Nunes et al (2002) measured immune function in 40 patients with depression, and 
compared them to the immune function of 34 matched non-depressed volunteers. 
Immune function as measured by acute phase proteins was significantly decreased in the 
depressed patients. However, NK cell levels were not tested. One notable strength of the 
study was the ratio of women to men in the depressed group (2.6:1), which mirrored the 
greater proportion of women diagnosed with depression. However, the lack of NK cell 
levels is not helpful (Nunes, Reiche et al., 2002). 
The development or progression of colorectal cancer has been linked to immune 
function since the 1980s. Decreases in immune function, either by design or nature, have 
been found to be associated with either the development or metastasis of colorectal or 
other cancers. Talmadge, Meyers, Prieur, & Stanley (1980) found an association between 
NK cells and tumor growth in mice (Talmadge, Meyers et al., 1980). Letsou, Ballantyne, 
Zdon, Cambria, & Modlen, (1985) reported increases in renal cell carcinoma in patients 
after renal transplant associated with drug-induced immunosuppression (Letsou, 
Ballantyne et al., 1986). Weese, Gilbertson, Syrjala, Whitney, & Starling, (1985) were 
able to reduce the incidence of colon cancer metastasis in mice through 
immunostimulation (Weese, Gilbertson et al., 1985). 
Immune System Function 
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The immune system discriminates between native and non-native cells within the 
body, and protects the body from invading pathogens. The immune system also carries 
out a significant internal surveillance function, designed to recognize cancer cells arising 
from errors in cell division, and eliminate them. Overly aggressive immune cells 
attacking the body's native cells have been implicated in the development of autoimmune 
disorders such as multiple sclerosis, insulin-dependent diabetes, rheumatic arthritis, and 
Crohn's disease, to name a few. 
There are two arms in the immune system: the humoral-mediated immune 
system, and the cellular-mediated system. Humoral immune responses include the B-
lymphocytes and their serological products, while the cellular-mediated system consists 
of the T-lymphocytes,, the thymus, lymph nodes, blood vessels, and spleen. Both B-
lymphocytes and T-lymphocytes arise from the bone marrow. T-lymphocytes migrate to 
the thymus gland in the neck, where they differentiate into several subtypes: cytotoxic T-
lymphocytes, known as natural killer (NK) cells, T-helper lymphocytes, and T-suppressor 
lymphocytes. The T-lymphocytes then travel to the blood vessels, lymph nodes, and 
spleen to await activation by a pathogen. B-lymphocytes are responsible for the 
antibody-mediated response to pathogens or abnormal internal cells. All B-lymphocytes 
begin their life spans as secretors of immunoglobulin M (IgM). 
When an invading organism or an abnormal cell is detected by the immune 
system, the macrophage mounts the first response. The macrophage cell surface engages 
the antigen with the major histocompatibility complex on the cell surface, leading to the 
secretion of interleukin-1 (IL-1). Interluekin-1 resets the hypothalamus to a higher normal 
set point, leading to the fever associated with infection; interleukin-1 also encourages the 
21 
proliferation of T-lymphocytes and B-lymphocytes. Both natural killer T-lymphocytes 
and helper T-lymphocytes respond to IL-1. Both natural killer and helper T-lymphocytes 
secrete immunoglobulins that modulate their adherence to major histocompatibility 
complexes formed by the interaction of macrophages and antigens. Natural killer T-
lymphocytes possess specific binding sites on their cell surfaces that recognize and bind 
antigens as the antigens are presented to them by the macrophage. The NK cell then 
recognizes and responds to that specific antigen, leading to a faster T-lymphocyte 
response when the antigen is encountered again. Natural killer lymphocytes are 
evaluated with the CD-8 count, a measure of the expression of Cluster Determinant 8. T-
helper lymphocytes are evaluated with the CD-4 count, a measure of the expression of 
Cluster Determinant 4. T-helper lymphocytes secrete interleukin-2, a cytokine, in 
response to antigens, and regulate the proliferation of T-lymphocytes in responses to 
antigens. When stimulated by T-helper lymphocytes secreting factors such as 
interleukin-2 and interleukin-4, B-lymphocytes change their antibody-secreting status and 
begin secreting other classes of antibodies (IgE, IgG, IgD) specific to the antigen 
presented to them by the T-helper cell. B-lymphocytes also proliferate at this stage, and 
maintain an antigen-specific response. 
Natural killer cell number and activity serves as quick method of evaluating 
immune system function, and has received some attention in the era of acquired immune 
system diseases. However, in patients with human immunodeficiency virus (HIV) 
infection, the CD-4 count has been used as a marker of HIV infection in patients prior to 




The review of the literature supports the research design of this study, and the 
examination of the study variables in the conceptual framework. The review points to the 
extraordinary lack of attention paid to the experiences of women in the study of 
colorectal cancer, and the implications of colorectal for patients' psychological well-
being. The majority of the studies did not include women, or did not analyze the women 
as a group separate from the men. Women are more likely to suffer from depression, and 
depression has been associated with reduced immune function. If women with colorectal 
is cancer are more depressed than men, one would expect that their immune function would 
suffer, leading to (potentially) more complications and poorer healing. 
In summary, the review of the literature indicates that further research is needed 
to examine the relationship between gender, depression, and immune function in patients 
with colorectal cancer. A secondary analysis of data which includes both men and 
women can be conducted to illuminate any relationships. The knowledge gained from 
this analysis could be used to formulate gender-specific treatment plans, and improve 
outcomes for patients with colorectal cancer. 
CHAPTER III 
METHOD 
The purpose of this study was to examine gender differences in the relationship 
between depression, and immune function in patients with colorectal cancer over time. In 
this chapter the research design, sample and sample, procedures for data collection, 
measurement, as well as the data analysis techniques are described. The protection of 
human subjects is also discussed. 
Design 
A descriptive, correlational, repeated measures design using secondary data 
analysis was used for this study. Polit and Beck define secondary analysis as a form of 
research in which the data collected by one researcher are reanalyzed by another 
researcher to answer new research questions (Polit and Beck, 2004 p. 731). Although the 
database must be selected with care, there are numerous advantages to conducting a 
secondary analysis. Perhaps the greatest advantage lies in the money, time, and resources 
which are conserved by using data which have already been collected (Moriarty, Deatrick 
et al., 1999). In addition, the researcher does not need to impose upon the time and 
patience of the members in the database, nor invade their privacy once again. If the 
sample is large enough, the database may contain considerably more variables than could 
be obtained in a smaller sample. A secondary analysis may allow the researcher to 
reexamine data, and rethink previous conclusions. Finally, the researcher may be able to 
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use a secondary analysis to as a preliminary study to solicit additional funds for further 
research (Moriarty, Deatrick et al., 1999). 
This study used a subsample of participants (n = 117) who participated in a larger 
study conducted by McCorkle and colleagues to examine the physiological and 
psychological responses over time of patients with colorectal cancer. The sample utilized 
in this study was selected for several reasons. The database consisted of unequal 
numbers of men and women. The unequal numbers may point to pre-existing differences 
between the groups in their willingness to participate, or to continue to participate once 
enrolled. The unequal numbers may reflect the overall demographic makeup of the 
population, or the tendency of women to request medical care later in an illness trajectory 
than men. Numerous other reasons may lie behind the unequal numbers, but the 
preponderance of men could make drawing conclusions problematic. 
The data were collected prospectively, included data collection points throughout 
the illness trajectory, and standardized measures of depression and immune system 
function, in addition to demographic data. Finally, the data were made available by the 
researcher who collected them, who encouraged the secondary analysis. 
McCorkle Study 
A repeated measure prospective design was used to examine the physiological 
and psychological responses over time of patients with colorectal cancer. 
Sample and Sampling 
Patients diagnosed with colorectal cancer were identified by the surgical 
scheduling offices and then recruited from the four hospitals of the University of 
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Pennsylvania for three months during their recovery from surgery from 1990 to 1992. To 
achieve a power of .80 using three independent variables and 2 covariates, based on R = 
.10 and alpha = .05, 121 were required for the study (Cohen 1988; Orsi, Tax et al. 1996). 
All subjects were selected on the basis of the following criteria: 
1. Dukes Stage A or B (TNM stages I and II) carcinoma of the colon or rectum. 
2. Scheduled for surgery for colon or rectal cancer. 
3. Able to communicate in English. 
4. Oriented to time, place, and person. 
Two hundred eligible patients were invited to join. Thirty-four percent refused, 
either 
due to fatigue or preoccupation, desire to avoid further blood draws, or family preference. 
After informed consent was obtained, participants were asked to complete a demographic 
survey, as well as an evaluation of the impact of their cancer on their state of mind, the 
Beck Depression Inventory. The Beck Depression Inventory (BDI) a 21 item self-report 
test measuring characteristic attitudes and symptoms of depression. Blood was drawn for 
lymphocyte assay, which was determined by flow cytometry measurements. The initial 
interview was conducted by a graduate student on the study team, and lasted between 30 
and 45 minutes. 
Data were collected prospectively at four points in time: 1) prior to surgery; 2) 1 
week after surgery; 3) 1 month after surgery; 4) 3 months after surgery (Orsi, Tax et al. 
1996). Each participant completed the Beck Depression Inventory each time. Blood 
samples were obtained for NK Cell Assay at the initial (pre-operative) visit, as well as at 
1 week and 3 months. 
Table 1. Data Collection Time points 
Time Point Prior to Surgery 1 Week 1 Month 3 Months 
Post-Op Post-op Post-op 
Measure Beck Beck Beck Beck 
NK Cell Assay NK Cell Assay NK Cell Assay 
The demographic make-up of the patients who began the study is presented 
below. Mean age of the participants was 62.4 years, with the mean age of the women 
equal to 62.0 years, and the mean age of the men 62.3 years. The participants were 
grouped according to their reports of depressive symptoms for the purposes of analysis 
(Orsi, McCorkle et al.,1996). Chi-square analyses were conducted to determine if there 
were any pre-existing differences between the demographics of the two groups. The 
groups were similar with the exception that those with no or minimal depressive 
symptoms were more likely to be married (X2 = 2.98, p - .05) (Orsi, McCorkle et al., 
1996). No differences were discerned with respect to age, employment, socioeconomic 
status, education, race, and presence or absence of an ostomy (Orsi, McCorkle et al. 
1996). Twenty-seven percent of the subjects were mild to moderately depressed 
according to the criteria established by the Center for Cognitive Therapy (Beck, Ward et 
al., 1961). 
Table 2. 
Gender Breakdown by Sampling Time 
PreOp 1 week 30 Days 90 Days 
Male n(%) 71(61%) 60(65%) 59(68%) 58(64%) 
Female n(%) 46(39%) 32(35%) 28(32%) 32(36%) 
Total n(%) 117(100%) 92(100%) 87(100%) 90(100%) 
The mean BDI score for those patients reporting more severe symptoms was 16.0 
(±7.5), indicating mild to moderate depressive symptoms (Orsi, McCorkle et al., 1996). 
The mean BDI score for the patients with no or minimal depressive symptoms was 3.3 
(±2.5). 
The original investigators used t tests to look for differences in the preoperative 
lymphocyte phenotype measure based on the demographic and clinical characteristics. 
They reported no significant differences in the phenotype measures on any of the 
demographic and clinical characteristics. However, they did find a clear and significant 
difference in the relative lymphocyte levels between those patients reporting minimal or 
no depressive symptoms, and those with depressive symptoms. Patients with depressive 
symptoms prior to surgery had lower NK cell levels and CD8 levels, as well as lower T 
helper (CD4) counts. Not surprisingly, their ratios of CD4 to CD8 were lower. Patients 
with more depressive symptoms had significantly higher T helper counts (CD4), and 
higher CD4/CD8 ratios, and significantly lower NK cell counts. Postoperatively, patients 
with an ostomy had significantly lower CD4 counts, and patients receiving adjuvant 
therapy had significantly lower CD4 counts, CD4/CD8 ratios, and significantly higher 
CD8 counts. The mean BDI score post surgery for patients reporting more depressive 
symptoms was 17.6 (±8.0), while the mean BDI score for patients with no or minimal 
depressive symptoms was 2.9 (±2.7). This translates to a moderate level of depression. 
At 3 months, patients in both groups had a slight increase in NK cell counts, and a 
significant decrease in depression scores as measured by the BDI. Patient who reported 
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depressive symptoms preoperatively continued to show significantly lower NK cell 
counts at the 6 month evaluation. 
The original team used stepwise multiple regressive analyses of the immune 
system to assess the impact of various factors on NK cell counts. The level of depressive 
symptoms reported, presence of an ostomy, occupation, and marital status predicted NK 
cell counts. The presence of more severe preoperative depressive symptoms explained a 
large amount of the variance in NK cell counts. Depression explained 7% of the variance 
in NK cell counts. Use of adjuvant therapy accounted for 10% of the variance in 
CD4/CD8 ratios at 6 months. The presence of an ostomy predicted 11% of the variance 
in CD4 counts after surgery. 
Overall, 27% of patients reported mild to moderate depression as measured by the 
BDI (Orsi, McCorkle et al., 1996). The 24 women constitute a cohort whose 
psychological state can be linked to their immune system function. Postoperative 
depression was present at the 3 month evaluation, which demonstrates an extraordinary 
duration of suffering. What is not known about this group of depressed patients is 
whether the men and women had different trajectories of depression, and how this might 
affect their eventual outcomes. 
Rose Study 
For the study presented here, 117 patient records were available for analysis. Of 
these 117 cases, there were 71 men and 46 women at the initial sampling time, and the 
ratio of men to women who remained in the sample was consistent at each sampling 
point. Attrition was 25% for men between Time 1 and Time 2, 0 between Time 2 and 










Time 1 and Time 2, 3% between Time 2 and Time 3, and 0 between Time 3 and Time 4. 
Table 3 presents the number and percentage of men and women who participated in the 
study at each sampling point. 
Table 3. 
Gender Breakdown by Sampling Time 
Pre-operative 1 week 
Male n (%) 71 (61%) 60 (65%) 
Female n (%) 46 (39%) 32 (35%) 
Total 117(100%) 92(79%) 
Unfortunately, demographic data on the patients were not made available for the 
purposes of this analysis, thus necessitating the use of previously published data. (See 
page 314, Orsi, McCorkle, et. al. (1996) 
Measurement 
Beck Depression Inventory 
Depression defined as a score of 21 was measured by the use of The Beck 
Depression Inventory (BDI) introduced by Beck, Ward, Mendelson, Mock, and Erbaugh 
in 1961, and revised in 1971. The Beck Depression Inventory is a 21 item self-report test 
measuring characteristic attitudes and symptoms of depression. It takes approximately 10 
minutes to complete, and requires a fifth or sixth grade reading ability. A shorter, 13 
item inventory is also available, but was not used in this study. Internal consistency 
ranges from 0.73 to 0.92, with a mean internal consistency of 0.86 (Beck, Steer et al., 
1988). Cronbach's alpha is 0.93. Content validity was obtained by review by experts in 
the symptoms of depressed patients. Concurrent validity with clinical ratings of 
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depression ranges from 0.62 to 0.66; there are moderate correlations between the revised 
Beck Depression Inventory and other depression scales, including the Hamilton 
Psychiatric Rating Scale for Depression (0.73), the Zung Self-Reported Depression Scale 
(0.76), and the Minnesota Multiphasic Personality Inventory Depression Scale (0.76) 
(Groth-Marnat, 1990). Groth-Marnat also reported that the revised Beck Depression 
Inventory was able to discriminate between psychiatric patients and non-psychiatric 
patients, and yielded relatively higher scores for patients with major depressive disorders 
as compared to patients with dysthymic disorders. Scores on the Beck Depression 
inventory range from zero to 63 in patients diagnosed with depression. The test is scored 
differently for the general population, and those who have diagnosed with depression. In 
both groups, higher scores indicate greater depression. In the general population, a score 
of 21 or greater indicates depression. In those patients diagnosed with depression, mild 
to moderate depression levels begin at 10-18, moderate to severe depression scores range 
from 19 to 29, and severe depression scores range from 30 to 63. Groth-Marnat (1990) 
suggested that any score above 40 was indicative of possible exaggeration of depression, 
and might be found in histrionic patients or those with borderline personality disorders. 
Scores below 4 were deemed below usual scores in normal persons, and might represent 
faking or denial of depression. For this analysis, subjects were assigned to one of two 
groups: minimal or no depressive symptoms (scores less than 21), and more severe 
depressive symptoms (scores 21 or greater) (Orsi, McCorkle et al., 1996). Continuous 
variables were used for this analysis. 
Flow Cytometry Evaluation 
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Flow cytometry was used to evaluate the numbers and types of immune cells. In 
flow cytometry, cells are measured by exposing them to fluorescent monoclonal 
antibodies that have been manufactured to react with the antigens present on each cell 
surface. After reacting with the fluorescent monoclonal antibodies, the resulting cell-
antibody complexes produce different colors and degrees of fluorescence, and are 
counted in flow cytometry chamber. Flow cytometry measurements have been used in 
predicting responses to bone marrow and solid organ transplantation, the evaluation of 
immune system dysfunction (Tax, Orsi et al., 1994). The results can be obtained in as 
little as two hours, and are reliable and reproducible (Tax, Orsi et al., 1994). Monoclonal 
antibodies against specific surface antigens on the lymphocytes were purchased from 
Becton-Dickinson (Mountain View, California). These antibodies had been conjugated 
with one of two fluorescing solutions: fluroescein isothiocyanate (FITC), which can be 
detected by green emission in the flow cytometer, or phycoerythrin (PE), which can be 
detected by red emission in the flow cytometer. Using two different fluorescing stains 
allows the lymphocytes to be labeled with two different antibodies. Samples of 
ethylenediaminetetraacetate (EDTA)-anticoagulated blood were incubated with the 
monoclonal antibodies. A lysing solution was then added to remove the erythrocytes, 
leaving the lymphocytes and platelets. The remaining cells were sedimented in a 
centrifuge, washed, and fixed in a parformaldehyde solution. A Becton-Dickinson FAC-
Scan flow cytometer was used to perform the two-color flow cytometry analysis as 
described by Siegal et al (1989). A sum check on the values obtained from the flow 
cytometry analysis for each patient was performed (Tcells + Bcells +NK cells = 100%) 
according to the Riechert method (Reichert, DeBruyere et al., 1991). Based on this 
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check, only 1 sample of the 95 obtained was eliminated from the analysis. The sum 
check for the remaining samples ranged from 95% to 105%, with a mean of 100%. 
Results from the flow cytometry analysis were expressed as percentages of lymphocyte 
phenotypes rather than absolute numbers of cells. 
Data Analysis 
The original investigator made Beck Depression Inventory and Natural Killer cell 
levels and gender available to this researcher. The data were entered by the researcher 
into a database of the Statistical Package for the Social Sciences (SPSS) version 16.0, 
Graduate Pack. Data entries were double-checked by the researcher and an associate, and 
no data entry errors were found. The study was approved by the Institutional Review 
Board for the protection of human subjects and the University of San Diego Institutional 
Review Board. 
Descriptive statistics were used in this analysis. Prior to statistical analysis, 
missing data points were identified and analyzed by gender. The drop-out rate was 
extraordinarily high, perhaps because of the longitudinal nature of the investigation. 
Missing data for both depression scores and NK cell levels were imputed using the 
General Estimating Equation analysis. 
Descriptive Statistics 
Descriptive statistics for the sample were drawn from the published work of the original 
investigators and used to compare the samples according to depressive symptom 
reporting (Munro 2001) (Orsi, McCorkle et al. 1996) (Tax, Orsi et al. 1994). 
Power Analysis 
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Power is influenced by the type of statistical test being performed, the size of the 
sample, the size of the effect being measured, and the level of error specified in the 
research. General estimating equation analysis was used to test for differences between 
the mean scores for depression and NK cell levels at four points in time for depression, 
and three points in time for NK cell levels, and between the two genders (Hanley, 
Negassa et al., 2003). General estimating equations (GEE) are of particular value when 
the data to be analyzed consist of longitudinal data, correlated data, in studies with 
considerable missing data points, or if the data are binary or counts (Hanley, Negassa et 
al., 2003). The GEE analysis is a regression analysis based on the General Linear Model 
(GLM), and develops a regression equation for each set of data points to impute missing 
data. The GEE method assumes that the model being tested is linear, and that any 
missing data are missing completely at random (Horton & Lipsitz, 1999; Norton, Bieler 
et al., 1996). General Estimating Equations are a synthesis of Feasible Generalized Least 
Squares approach and are of particular value in data sets with missing data. General 
Estimating Equations produce reasonably accurate standard errors, which produces 
confidence intervals with the correct coverage rates (Hanley, Negassa et al., 2003). 
The size of the sample required to demonstrate an effect can be the limiting factor 
in an investigation. If the effect is small, the size of the sample may need to be extremely 
large, and prohibitively expensive. If the effect is large, a smaller sample size may be 
required. The power analysis used by the original investigators led them to recruit 200 
participants. The size of the effect, in this case the sex of the participants, has been 
shown to be significant in other studies of depression as noted earlier, but not in studies 
of natural killer cells. The simplest approach to determine power in this analysis is to 
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estimate the effect size, or eta-squared (n ). Eta-squared represents the proportion of the 
variance explained by the analysis (Polit & Beck, 2004) p.498). Finally, the level of error 
was set a priori at/K0.05. 
Table 4 
Schedule of Tests for Men and Women Participants 
Prior to Surgery 
Sex 
Men BDI 





NK Cell Assay 
BDI 









NK Cell Assay 
BDI 
NK Cell Assay 
There were several limitations to this study. While the overall number of 
participants was moderately sized, not all the data could be retrieved. The data were also 
drawn from the catchment area of a large metropolitan hospital in the northeastern corner 
of the United States, and included primarily elderly participants. Seventy-four percent of 
the participants were over the age of 56. Since 91% of new diagnoses of colorectal 
cancer occur in patients over the age of 50, it is likely that this sample underestimates the 
population mean for depressive scores and NK cell levels. The data were gathered in the 
1990s. Since that time, colorectal cancer has received more publicity and more attention 
from the public, particularly since the death of newscaster Katie Couric's husband in 
1998. After Couric underwent a televised colonoscopy in 2000, a study published in the 
Archives of Internal Medicine noted an increase in patients undergoing colonoscopy for 
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cancer screening. In addition, only 9 participants (10%) were African-American. 
African-Americans die from colorectal cancer at 40% higher rate than Caucasian men 
and women, and are more likely to be diagnosed at a more advanced stage of the disease 
(ACS, 2005). 
Finally, the data are limited by the attrition rate. The treatment of the missing 
data has already been discussed. By the time of the first post-operative visit, one week 
after surgery, 15% of the men and 30% of the women had dropped out of the study or 
simply did not complete their depression score instruments. At one month, an additional 
2% of men and 9% of women were lost to follow-up, and at three months, a total of 18% 
of men and 30% of women had dropped out of the investigation. At all data points, 
women were lost to follow-up at approximately twice the rate of men. 
Similar results were found when the NK cell counts were analyzed. Results were 
available for 55 men and 34 women at the pre-operative visit. By the time of the post-
operative interview at 1 week, 29% of men had opted out, and 38% of women. At three 
months, 36% of men and 42% of women dropped out of the study or their results could 
not be found. At all points, more women than men dropped out. 
Human Subjects 
To protect participants from risk or injury, the original investigators submitted the 
study proposal to the Committee on Studies Involving Human Beings at the University of 
Pennsylvania. For the secondary analysis, the proposal was submitted for approval by 
this investigator to the Institutional Review Board of the University of San Diego. 
Appendix B contains the approval letter from the University of San Diego. The original 
investigators hold the approval letter from the University of Pennsylvania. 
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The data collection tools were kept locked in a secure location by the original 
investigators, and made available to this researcher. All participants were coded by 
numbers rather than by names, and the original investigators kept the names separately 
from the coded data tools to maintain anonymity. 
There were no potential physical, psychological, or social risks to the subjects in 
this secondary analysis. The findings will be used to assess the relationship, if any, 
between gender and depression and natural killer cell levels in patients with colorectal 
cancer. 
Summary 
The purpose of this study was to investigate the influence of gender on depression 
and natural killer cell levels in patients with colorectal cancer over a 3 month period. The 
data analysis is appropriate for the types of data collected, the purpose of the study, and 
the method used. It is hoped that the results of the data analysis provided information 
useful in the formulation of treatment plans for patients with colorectal cancer. 
CHAPTER IV 
RESULTS 
The results of the analysis are presented in two sections. Section one describes 
the sample's demographics. Section two presents the analysis of the influence of gender 
on participants' reporting of depressive symptoms, and NK cell levels. 
Description of the Sample 
The demographic breakdown of the sample can be found in Table 5. The original 
investigators used t tests to look for differences in the preoperative lymphocyte 
phenotype measure based on the demographic and clinical characteristics. They reported 
no significant differences in the phenotype measures on any of the demographic and 
clinical characteristics. However, they did find a clear and significant difference in the 
relative lymphocyte levels between those patients reporting minimal or no depressive 
symptoms, and those with depressive symptoms. Patients with depressive symptoms 
prior to surgery had lower NK cell levels and CD8 levels, as well as lower T helper 
(CD4) counts. Not surprisingly, their ratios of CD4 to CD8 were lower. Patients with 
more depressive symptoms had significantly higher T helper counts (CD4), and higher 
CD4/CD8 ratios, and significantly lower NK cell counts. Postoperatively, patients with 
an ostomy had significantly lower CD4 counts, and patients receiving adjuvant therapy 
had significantly lower CD4 counts, CD4/CD8 ratios, and significantly higher CD8 
counts. The mean BDI score post surgery for patients reporting more depressive 
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symptoms was 17.6 (±8.0), while the mean BDI score for patients with no or minimal 
depressive symptoms was 2.9 (±2.7). This translates to a moderate level of depression. 
At 3 months, patients in both groups evinced a slight increase in NK cell counts, and a 
significant decrease in depression scores as measured by the BDI. Patient who reported 
depressive symptoms preoperatively continued to show significantly lower NK cell 
counts at the 6 month evaluation. 
The original team used stepwise multiple regressive analyses of the immune 
system to assess the impact of various factors on NK cell counts. The level of depressive 
symptoms reported, presence of an ostomy, occupation, and marital status predicted NK 
cell counts. The presence of more severe preoperative depressive symptoms explained a 
large amount of the variance in NK cell counts. Depression explained 7% of the variance 
in NK cell counts. The presence of an ostomy predicted 11% of the variance in CD4 
counts after surgery. 
Table 5 
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In the sample available to this researcher, a descriptive analysis was performed 
for both depression scores and NK cell levels. Women exhibited higher depression 
scores as measured by the BDI at all points in time (pre-op, one week post-op, 1 month 
post-op, and three months post-op), but the results were not statistically significant 
F(3,159) = 1.21, p = .303 (partial n = .022), and Greenhouse-Geisser = .68. The small 
effect size and small sample size (21) require that results be interpreted with caution. 
Individual histograms of the depression scores at each sampling point revealed that the 
scores were not normally distributed. All were positively skewed, making statistical 
inferences more difficult. To this end, the Greenhouse-Geisser correction was employed 
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to make the analysis more robust. A logarithmic transformation was considered, but did 
not increase the analytic power, and so was discarded. 
General estimating equation analysis was used to test for differences between the 
mean scores for depression and NK cell levels at three points in time across the illness 
trajectory, and between the two genders (Hanley, Negassa et al., 2003). General 
estimating equations (GEE) are of particular value when the data to be analyzed consist 
of longitudinal data, correlated data, in studies with considerable missing data points, or 
if the data are binary or counts (Hanley, Negassa et al., 2003). The GEE analysis is a 
regression analysis based on the General Linear Model (GLM), and develops a regression 
equation for each set of data points to impute missing data. The GEE method assumes 
that the model being tested is linear, and that any missing data are missing completely at 
random (Horton & Lipsitz, 1999; Norton, Bieler et al., 1996). General Estimating 
Equations are a synthesis of Feasible Generalized Least Squares approach and are of 
particular value in data sets with missing data. General Estimating Equations produce 
reasonably accurate standard errors, which produces confidence intervals with the correct 
coverage rates (Hanley, Negassa et al., 2003). 
Table 6 
Mean BDI Scores by Gender 
PreOp 1 Week 1 Month 3 Months 
Male 6.0 7.9 6.5 5.3 
Female 7.6 9.2 9.6 6.3 
The analysis for time reveals that the largest depression scores on the BDI were reported 
at one week after surgery, and that depression scores progressively declined from that 
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peak to a low at three months for men. In women, the highest depression scores on the 
BDI were reported at one month after surgery, and the lowest at the three month mark. 
Both men and women reported lower depression scores at three months than 
preoperatively. No data were available on the mobilization of social and family supports 
for the participants after the diagnosis, but presumably this did occur. More than three 
quarters of the sample (77%) were married, and it is reasonable to assume that there was 
spousal support. 
Table 7 
Mean NK levels by Gender 
PreOp 1 Week 3 Months 
Male 257 261 267 
Female 254 251 238 
Women in the sample available to this researcher exhibited lower NK cell levels 
preoperatively, at one week, and lower scores at 3 months than men. Individual 
histograms of the NK cell levels at each sampling point revealed that the levels were not 
normally distributed. All were positively skewed, making statistical inferences more 
difficult. The Greenhouse-Geisser correction was employed to make the analysis more 
robust. Logarithmic transformation did not increase the power of the analysis, and was 
not used. 
Data Analysis Related to the Research Question 
Research Question 1 Are women more likely to report more depressive symptoms than 
men in adult patients diagnosed with colorectal cancer at four points in time (pre-surgical, 
1 week post-surgery, one month post-surgery, and three months post surgery)? 
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While women did report higher depression scores than men at all points in time, 
the results were not statistically significant (B=2.065,p=A5l). Age was also statistically 
significant (B=4.180,/?=041). 
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Table 8 Beck Depression Scores and Gender: 
2 (Group) by 4 (Time) General Estimating Equation and Multi-Level Modeling (Â = 117) 
Men Women F 
Variables (Range) X (SD) X (SD) Group P W 
Beck Depression Score (0-63) 2.065 T51 .022 
Timel(n=71) 5.96(6.39) 
Time 2 (n=60) 7.93 (8.53) 
Time3(n=59) 6.54 (7.19) 
Time4(n=58) 5.34 (6.49) 
Beck Depression Score (0-63) 
Time 1 (n==46) 7.56 (5.86) 
Time2(n=32) 9.19(6.48) 
Time3(n=28) 9.61(5.86) 
Time 4 (n=32) 6.28 (6.20) 
Age (Men, 25-82) 62.6(12.8) 4.18 .041 
Age (Women,30-87) 62(12.8) 
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c Partial eta squared values are for the interactions only. Effect sizes: Small = .01, Medium = .06, Large = .1 
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Research Question 2 Do women demonstrate lower NK cell levels in adult patients 
diagnosed with colorectal cancer at three points in time (pre-surgical, one week post-
surgery, and three months post surgery)? 
Women did not demonstrate statistically significantly lower NK cell levels than 
men (B=.271, p-.603) using GEE, although at all points in time, men's NK cell levels 
were higher than women's. Age was not a significant factor in NK cell level differences 
(B=3.667,;?=056). 
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Table 9 Natural Killer Cell Levels and Gender: 









Natural Killer Cell Levels (42-
811) 
Time 1 (n=55) 
Time2(n=41) 




.239 .625 .014 
Natural Killer Cell Levels (42-
811) 
Time 1 (n=34) 
Time 2 (n=21) 




Age (Men, 25-82) 





'Partial eta squared values are for the interactions only. Effect sizes: Small = .01, Medium = .06, Large = .15 
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Summary 
This chapter presented the data analysis results for the research questions in three 
sections. The first section described the sample. Section two discussed the analysis of 
the effect of sex on depression scores. Section three described the influence of sex on 
natural killer cell levels. An assessment of effect size was included in sections two and 
three. There was no statistically significant association between sex and depression 
scores, and no statistically significant association between sex and NK cell levels. Age 
was a statistically significant factor in depression scores using the GEE analysis and the 
multi-level model, but was not significant in either analysis for effects on NK cell levels. 
CHAPTER V 
SUMMARY, DISCUSSION, IMPLICATIONS, AND CONCLUSION 
This chapter includes a summary of the research design and method, discussion of 
the research findings, implications for nursing practice, education, and research, and the 
conclusion of the research study. 
Summary of the Research Design and Method 
The purpose of this was to examine the relationship between gender, depression, 
and immune system status in individuals undergoing treatment for colorectal cancer at the 
University of Pennsylvania between 1990 and 1991. The conceptual framework for the 
study was based on McCorkle's work integrating expectations about outcome of cancer 
treatment, depression, and immune response in person recovering from surgery for 
colorectal cancer, and research asserting that women experience more depression than 
men when diagnosed with cancer. Depression was defined as the participant's score on 
the Beck Depression Inventory, and immune system status was defined as the 
participant's natural killer cell level. Depression was assessed at four points in time: 
preoperatively, one week, one month, and three months post-surgery. Immune system 




The following research questions were addressed: 
1. Are women more likely to report more depressive symptoms than men in adult 
patients diagnosed with colorectal cancer at four points in time (pre-surgical, 1 week 
post-surgery, one month post-surgery, and three months post surgery)? 
2. Do women demonstrate lower NK cell levels in adult patients diagnosed with 
colorectal cancer at three points in time (pre-surgical, one week post-surgery, and three 
months post surgery)? 
Data provided by the original researcher, collected between 1990 and 1991, were 
analyzed using SPSS for Windows. Descriptive statistics were reported by the original 
researcher, and inferential statistics were used by this researcher to examine the 
relationships between the study variables of gender, depression, and immune system 
status. The results of the study did not support a link between gender and depression, or 
between gender and immune system status. However, the lack of power was a 
confounding factor. A discussion of the results of the study is presented in the next 
section of this chapter. 
Discussion 
Descriptive Characteristics of the Sample and Study Variables 
Results for the two research questions on the effects of gender on Depression and 
the Immune System will be discussed separately due to differing numbers in each sample. 
Research Question 1: Are women more likely to report more depressive symptoms than 
men in adult patients diagnosed with colorectal cancer at four points in time (pre-surgical, 
1 week post-surgery, one month post-surgery, and three months post surgery)? 
51 
A total of 117 people with colorectal cancer participated in the study, but the drop 
out rate was high, and contributed to the lack of power. Of the 117, 55 completed the 
depression score inventories at three points: prior to surgery, one week post-surgery, one 
month post-surgery, and three months post-surgery. The sample consisted of 34 men 
(62%) and 21 women (38%). The sample was overwhelmingly Caucasian (90%) and 
married (77%). The majority of participants (57%) had completed college, and most 
worked or had worked as either skilled workers (50%) or as professionals (45%). Their 
ages ranged from 28 years to 88 years, with a mean of 63 years. According to the 
American Cancer Society(ACS, 2005), the incidence of colorectal cancer is more than 50 
times higher in patients aged 60 years to 79 years than in those younger than in those 
aged less than 40 years old. In these respects, the study participants differ from the 
American Cancer Society's description of people with colorectal cancer. The sample 
included only 10% African-Americans, and the number of patients aged 60 years to 79 
years with colorectal cancer was seven times greater than those aged less than 40 years. 
According to data released in 2005, 91% of new cases occur in patients older than 50 
years, and the incidence is 35% higher in men than in women (ACS, 2005). Colorectal 
cancer incidence is approximately 15% higher in African-American men and women than 
in Caucasian men and women in the general population than in this sample. African-
American patients are more likely to be diagnosed with colorectal cancer that has already 
metastasized than Caucasians, and are less likely to receive chemotherapy and adjuvant 
therapies than Caucasians (ACS, 2005). No data on chemotherapy and adjuvant therapies 
stratified by race were available, and the small number of African-American participants 
makes any conclusions risky. The sample consisted of 61% men and 39% women with 
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colorectal cancer. The men represent a 56% increase in the incidence of colorectal 
cancer, in contrast to the ACS statistics, which state that the incidence and mortality of 
colorectal cancer is more than 35% higher in men than women (ACS, 2005). 
Women reported more depressive symptoms than men at every point in time, but 
the results were not statistically significant using both General Estimating Equations and 
Multi-level Modeling analyses. The small effect size and small sample size make the 
results difficult to trust. The lack of power made conclusions about the effect of gender 
difficult. 
Analysis did reveal a significant main effect for age on depression scores. This 
result has been previously reported (Orsi, McCorkle et al., 1996). The analysis for time 
reveals that the largest depression scores on the BDI were reported at one week after 
surgery, and that depression scores progressively declined from that peak to low at three 
months. Both men and women reported lower depression scores at three months than 
preoperatively. Some of this change in depression scores can be attributed to the effects 
of being involved in an altruistic endeavor, the study itself. No data were available on the 
mobilization of social and family supports for the participants after the diagnosis, but 
presumably this did occur. More than three quarters of the sample (77%) were married, 
and it is reasonable to assume that there'was spousal support. 
There were not significant changes in the number of participants in the 
Depression Score portion of the study. In all probability, this is due to the nature of the 
instrument used, the Beck Depression Inventory. The BDI can be self-administered or 
the data can be collected in an interview. Neither method is particularly intrusive, and 
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there is no physical pain associated with the test, as is the case for the phlebotomy 
required to obtain NK cell results. 
Research Question 2: Do women demonstrate lower NK cell levels in adult patients 
diagnosed with colorectal cancer at three points in time (pre-surgical, one week post-
surgery, and three months post surgery)? 
Women did demonstrate lower NK cell levels than men at all sample times (pre-
operative, one week, and three months, but the results were not statistically significant. 
There was no significant effect for time, ignoring sex. The results were complicated again 
by the small sample size and the decreasing number of participants over time. The 
number of participants declined from 60 at the pre-operative sample to 51 at one week, 
and 45 at three months. Only 16 women were participating by the three month time 
frame. 
The high attrition rate for women was especially troubling, since colorectal cancer 
strikes almost as many women as breast cancer. Yet data on women are lacking. No data 
were available from the original researchers regarding the reasons for the women 
dropping out of the study. 
Implications for Nursing 
Nursing Education 
This study has implications for nursing education, in that little attention continues 
to be paid to the impact of disease states on women. The majority of the patients in this 
study were men, and a significant effect was found between time and depression. 
According to the World Health Organization (WHO), depression represents one of the 
most burdensome diseases facing the world (WHO, 2002). Depression occurs in up to 20 
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percent of patients with chronic medical illnesses such as diabetes and heart disease, and 
presumably, colorectal cancer. Depression is also associated with an approximately 50% 
increase in medical costs of chronic medical illness (Katon 2003). 
Women are at greater risk for late-life depression, coinciding with the most likely 
years for a diagnosis of colorectal cancer. The prevalence of depression is higher in 
women across all age groups. Several factors may account for the disproportionate 
prevalence of depression in older women: greater susceptibility to depression, greater 
persistence of depression after its onset, and lower mortality (Barry, Allore et al., 2008). 
Although the gender gap in depression prevalence narrows with increasing age, women 
remain at higher risk (Kornstein, 1997). Women make up the majority of nurses and 
nursing students, yet nursing education focuses little to no attention on the psychological 
and physiological differences between men and women. The women in this admittedly 
small sample consistently reported more depressive symptoms, and demonstrated lower 
NK cell levels. While the results were not statistically significant, the potential 
implications should be considered in teaching. According to literature, women are much 
more likely to report depression than men, yet women are treated less often and less 
effectively. Nursing education needs to emphasize the special needs of women in 
recovering from major surgery such as colorectal surgery, and in the course of coping 
with a life-threatening disease. Social support may also influence depression and coping 
differently in women than in men. In 2005, Kristofferzon, Lofmark, and Carlsson, studied 
74 women and 97 men diagnosed with myocardial infarction in Sweden. The women 
used more evasive and supportive coping, and rated psychological aspects of the heart 
disease as more problematic to manage. More women perceived available support from 
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friends and grandchildren, and more men perceived available support from their partner ( 
Kristofferzon, Lofmark,& Carlsson, 2005). Manning-Walsh (2005) studied 100 women 
with breast cancer, and found that social support from friends and family members helped 
decrease the negative effects of symptoms on quality of life (Manning-Walsh, 2005). 
Considerable differences exist, moreover, between sources of social support in men and 
women. Gass, Weitzen, Clark, and Dizon studied 135 women diagnosed with breast 
cancer, 75% of whom were married or partnered. Asked to name their primary support, 
emergency contact, and health care proxy, more than 40% of women did not name the 
same person to these distinct roles. Even for women in relationships, almost 50% did not 
name their partner to all 3 support roles. (Gass, Weitzen, Clark, et. al., 2007). It would be 
particularly interesting to study the effects of non-spousal support on coping with cancer 
in married men and married women. In addition, comparing the sources of support in 
married and single women with cancer could provide insight into designing support 
systems for those women facing a diagnosis of cancer. 
Nursing Research 
This study presents a number of issues for nursing research. Women represent 
46% of all patients diagnosed with colorectal cancer, yet this is the only longitudinal 
study to address the effects of the disease on their state of mind and their immune 
systems. A great deal of attention was paid to the Couric effect on colorectal cancer 
screening rates, but little attention has focused on the effects of the treatment course on 
women. Women have long been known to have an increased risk of depression, but there 
have been no intervention studies published which focus on how to treat depression in 
women with colorectal cancer. 
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The small number of women participating in this study makes additional research 
imperative. The sample also did not include significant numbers of African-American 
participants, yet this group has a 15% higher incidence of colorectal cancer, and a 40% 
higher mortality (ACS, 2005). Additional research on the impact of the disease and its 
treatment on depression and immune system status in the African-American population 
must be undertaken. 
This study used NK cell levels as a marker of immune system function. It would 
be helpful to investigate immune system function, such as infection to determine if the 
NK cell levels are clinically significant. 
Summary of recommendations for further study 
Additional research is needed in women with colorectal cancer, and in African-
Americans with colorectal cancer. Studies to determine the efficacy of interventions to 
combat depression in women and improve immune system status would be particularly 
helpful. Additional work is needed to determine if the depression levels and immune 
system changes are clinically significant. 
Conclusion 
This secondary analysis examined the influence of sex on depression and immune 
status in patients with colorectal cancer over a three month period. No significant effects 
were found, but the study was confounded by the small sample size. A significant main 
effect for time was found on depression in the entire sample, but not in separate sexes. 
Additional research is needed to examine the impact of sex on depression and immune 
status, and to look for clinically significant changes, if any, in this patient population. 
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Primary Tumor (T) 
TX: Primary tumor cannot be 
assessed 
TO: No evidence of primary 
tumor 
Tis: Carcinoma in situ: 
intraepithelial or invasion of 
the lamina propria. 
Tl: Tumor invades submucosa 
T2: Tumor invades muscularis 
propria 
T3: Tumor invades through 
the muscularis propria into the 
subserosa or into 
nonperitonealized pericolic or 
perirectal tissues 
T4: Tumor directly invades 
other organs or structures 





nodes cannot be 
assessed 
NO: No regional 
lymph node 
metastasis 
Nl: Metastasis in 1 
to 3 regional 
lymph nodes 
N2: Metastasis in 4 




























T2, NO, MO 
T3, NO, MO 





Any T, N2, MO 
Treatment 


















































In the past, colorectal cancer was staged primarily according to the Duke's classification 
system. The Duke's system sorted tumors into four categories (A, B, C, D) according to 
the extent of tumor penetration into the colon, surrounding tissue, and distant sites. 












Extent of Tumor 
Cancer has spread beyond the 
innermost lining of the colon 
and/or rectum to the second and 
third layers and involves the 
inside wall of the colon and/or 
rectum, but it has not spread to 
the outer wall or outside the 
colon and/or rectum. 
Cancer has spread outside the 
colon and/or rectum to nearby 
tissue, but it has not gone into 
the lymph nodes 
Tumor cells have spread to 
organs and lymph nodes near 
the colon/rectum 
Cancer may have spread to 
nearby lymph nodes and has 
Prognosis 
97% 5 year survival 




CI: only a few nodes are 
involved near the primary 
growth and the proximal 
nodes are free from 
metastases, 65% 5 year 
survival. 
C2: proximal nodes are 
involved, 35% 5 year 
survival 
less than 5% 5 year 
65 
spread to other parts of the 
body, such as the liver or lungs. 
survival 
